Home Health Merck’s COVID-19 Pill May Be Less Effective Than First Hoped Merck’s COVID-19 Pill May Be Less Effective Than First Hoped By admin - November 29, 2021 36 0 According to an analysis by scientists at the FDA, the experimental pill cut the risk of hospitalization or death from COVID-19 by about 30% compared to a placebo. RELATED ARTICLESMORE FROM AUTHOR Musk’s-brain-implant-company-hiring-clinical-trials-director Infertility Amid COVID-19: ‘Our Hopes Were Taken Away’ Booster Shots 90% Effective at Preventing Omicron Hospitalizations: CDC Data Depression Might Influence Belief in COVID Vaccine Lies Doctors Fight Tobacco Takeover of Inhaled Medicines ‘Post-Truth Era’ Hurts COVID-19 Response, Trust in Science Is Havana Syndrome Real? Here’s What History Can Tell Us 'The Other Pandemic': Antibiotic Resistance Growing Worldwide 'Artificial Pancreas' Can Help Kids With Type 1 Diabetes Ordering Groceries Online? Good Luck Finding Nutrition Info LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment.